☆TANG CAPITAL MANAGEMENT LLC
Quality Q
0.706
AUM ($M)
2,202
Positions
41
Turnover
0.16
Top-10 wt
63%
Herfindahl
0.051
History (qtrs)
6
Excess Return
+40.3%
AI Eval Run AI Eval
Holdings · 56 positions · portfolio value $2,202M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆AUPH funds › | AURINIA PHARMACEUTICALS INC | ADD | — | 10.1% | +0.8% | 221.4 | 13,044,106 | +814,606 | 5 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | HOLD | — | 7.6% | +2.8% | 168.0 | 1,892,200 | +0 | 5 | — |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | HOLD | — | 6.6% | +0.8% | 144.7 | 1,236,027 | +0 | 5 | — |
| ☆KNSA funds › | KINIKSA PHARMACEUTICALS INTL | HOLD | — | 6.6% | +1.0% | 144.5 | 2,259,889 | +0 | 5 | — |
| ☆CELC funds › | CELCUITY INC | ADD | — | 6.2% | +0.2% | 137.5 | 1,314,594 | +264,594 | 4 | +55.9% |
| ☆CORT funds › | CORCEPT THERAPEUTICS INC | HOLD | — | 5.9% | +2.9% | 130.4 | 1,500,000 | +0 | 3 | +52.3% |
| ☆PTCT funds › | PTC THERAPEUTICS INC | HOLD | — | 5.6% | +0.4% | 122.4 | 1,500,000 | +0 | 5 | — |
| ☆LKFT funds › | LAKEFRONT BIOTHERAPEUTICS NV | HOLD | — | 5.2% | -0.6% | 113.5 | 3,785,991 | +0 | 5 | — |
| ☆CAPR funds › | CAPRICOR THERAPEUTICS INC | ADD | — | 4.5% | -0.8% | 98.7 | 4,099,900 | +700,000 | 3 | -1.0% |
| ☆TARS funds › | TARSUS PHARMACEUTICALS INC | ADD | — | 4.5% | +0.2% | 98.7 | 1,568,266 | +379,642 | 5 | — |
| ☆SPY funds › | STATE STR SPDR S&P 500 ETF T | TRIM | — | 4.2% | -1.4% | 91.9 | 123,000 | -45,000 | 3 | +0.0% |
| ☆ANAB funds › | ANAPTYSBIO INC | HOLD | — | 4.1% | +0.3% | 89.8 | 1,330,879 | +0 | 5 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | HOLD | — | 3.8% | -0.2% | 84.1 | 2,649,368 | +0 | 5 | — |
| ☆CMPS funds › | COMPASS PATHWAYS PLC | ADD | — | 3.2% | +2.1% | 70.8 | 5,000,000 | +997,800 | 2 | +188.5% re-entry |
| ☆ANIP funds › | ANI PHARMACEUTICALS INC | HOLD | — | 2.7% | -0.1% | 58.6 | 707,500 | +0 | 5 | — |
| ☆BNTX funds › | BIONTECH SE | HOLD | — | 2.0% | -0.1% | 43.7 | 470,000 | +0 | 5 | — |
| ☆CMPX funds › | COMPASS THERAPEUTICS INC | ADD | — | 1.8% | -2.7% | 39.4 | 17,990,782 | +1,199,973 | 5 | — |
| ☆PGEN funds › | PRECIGEN INC | HOLD | — | 1.7% | +0.4% | 36.6 | 6,417,500 | +0 | 4 | +85.9% |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | HOLD | — | 1.5% | -0.3% | 32.9 | 1,792,626 | +0 | 5 | — |
| ☆NVCT funds › | NUVECTIS PHARMA INC | NEW | — | 1.3% | +1.3% | 28.5 | 1,550,000 | +1,550,000 | 1 | +1084.9% |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | HOLD | — | 1.2% | +0.0% | 25.8 | 264,692 | +0 | 5 | — |
| ☆FULC funds › | FULCRUM THERAPEUTICS INC | NEW | — | 1.1% | +1.1% | 23.9 | 6,521,412 | +6,521,412 | 1 | -111.0% |
| ☆AVIR funds › | ATEA PHARMACEUTICALS INC | HOLD | — | 1.0% | -0.3% | 22.4 | 4,814,700 | +0 | 5 | — |
| ☆CBIO funds › | CRESCENT BIOPHARMA INC. | HOLD | — | 0.9% | -0.1% | 20.9 | 1,160,000 | +0 | 5 | -51.5% |
| ☆NNDM funds › | NANO DIMENSION LTD | NEW | — | 0.9% | +0.9% | 20.7 | 14,292,813 | +14,292,813 | 1 | +5.8% |
| ☆VKTX funds › | VIKING THERAPEUTICS INC | HOLD | — | 0.9% | +0.1% | 19.5 | 500,000 | +0 | 5 | — |
| ☆NUVB funds › | NUVATION BIO INC | ADD | — | 0.9% | +0.2% | 18.7 | 3,299,557 | +150,000 | 5 | — |
| ☆IDYA funds › | IDEAYA BIOSCIENCES INC | HOLD | — | 0.8% | +0.0% | 16.8 | 450,000 | +0 | 4 | +27.3% |
| ☆CUSIP:38341PAA0 funds › | GOSSAMER BIO INC | NEW | — | 0.5% | +0.5% | 11.5 | 17,841,000 | +17,841,000 | 1 | — |
| ☆DERM funds › | JOURNEY MED CORP | HOLD | — | 0.5% | +0.1% | 11.4 | 1,610,000 | +0 | 5 | — |
| ☆INSM funds › | INSMED INC | TRIM | — | 0.5% | -1.7% | 10.7 | 100,000 | -160,000 | 5 | — |
| ☆STOK funds › | STOKE THERAPEUTICS INC | TRIM | — | 0.4% | -0.4% | 9.8 | 300,000 | -200,000 | 5 | — |
| ☆PLRX funds › | PLIANT THERAPEUTICS INC | TRIM | — | 0.3% | -0.1% | 7.0 | 6,141,261 | -1,871 | 5 | — |
| ☆BOLD funds › | BOUNDLESS BIO INC | NEW | — | 0.3% | +0.3% | 6.4 | 2,559,875 | +2,559,875 | 1 | +1625.9% |
| ☆PMVP funds › | PMV PHARMACEUTICALS INC | HOLD | — | 0.3% | -0.0% | 5.7 | 4,245,085 | +0 | 4 | -39.2% |
| ☆MRNA funds › | MODERNA INC | TRIM | — | 0.2% | -0.1% | 3.5 | 50,000 | -50,000 | 5 | — |
| ☆WVE funds › | WAVE LIFE SCIENCES LTD | HOLD | — | 0.2% | -0.1% | 3.5 | 600,000 | +0 | 3 | -55.9% |
| ☆HRTX funds › | HERON THERAPEUTICS INC | HOLD | — | 0.1% | -0.1% | 2.7 | 6,250,000 | +0 | 5 | — |
| ☆LENZ funds › | LENZ THERAPEUTICS INC | HOLD | — | 0.1% | -0.1% | 2.6 | 451,114 | +0 | 5 | — |
| ☆ALT funds › | ALTIMMUNE INC | HOLD | — | 0.1% | -0.0% | 2.0 | 666,022 | +0 | 5 | — |
| ☆RCKT funds › | ROCKET PHARMACEUTICALS INC | HOLD | — | 0.0% | -0.0% | 0.3 | 100,000 | +0 | 5 | — |
| ☆AGIO funds › | AGIOS PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -100,000 | 0 | -33.3% |
| ☆URGN funds › | UROGEN PHARMA LTD | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -350,000 | 0 | +262.8% |
| ☆EOLS funds › | EVOLUS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -483,021 | 0 | — |
| ☆CUSIP:483497103 funds › | KALVISTA PHARMACEUTICALS INC | EXIT | — | 0.0% | -4.7% | 0.0 | 0 | -4,573,530 | 0 | — |
| ☆CUSIP:65487U108 funds › | NKARTA INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -1,480,823 | 0 | — |
| ☆FATE funds › | FATE THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -1,167,773 | 0 | — |
| ☆JANX funds › | JANUX THERAPEUTICS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -500,000 | 0 | -11.4% re-entry |
| ☆NMRA funds › | NEUMORA THERAPEUTICS INC. | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -439,878 | 0 | — |
| ☆ERAS funds › | ERASCA INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -200,000 | 0 | — |
| ☆CHRS funds › | COHERUS ONCOLOGY INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -1,886,748 | 0 | — |
| ☆LXRX funds › | LEXICON PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -399,700 | 0 | +571.5% |
| ☆CUSIP:49372L209 funds › | KEZAR LIFE SCIENCES INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -664,314 | 0 | — |
| ☆BIIB funds › | BIOGEN INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -35,000 | 0 | — |
| ☆ARVN funds › | ARVINAS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -538,658 | 0 | — |
| ☆ABEO funds › | ABEONA THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -400,000 | 0 | +17.3% |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2,202 | 41 | 0.16 | 63% | 0.051 | 0.703 | — | in |
| 2026Q1 | 1,969 | 51 | 0.23 | 58% | 0.046 | 0.538 | — | in |
| 2025Q4 | 2,024 | 75 | 0.38 | 53% | 0.037 | 0.173 | — | in |
| 2025Q3 | 2,598 | 194 | 0.18 | 37% | 0.021 | 0.414 | — | in |
| 2025Q2 | 1,978 | 200 | 0.18 | 35% | 0.019 | 0.406 | — | entered |
| 2025Q1 | 1,808 | 202 | 0.00 | 39% | 0.022 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status